The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
15.22
-0.02 (-0.13%)
Aug 13, 2026, 12:55 PM EDT - Market open
The Chemours Company Employees
The Chemours Company had 5,700 employees as of December 31, 2025. The number of employees decreased by 300 or -5.00% compared to the previous year.
Employees
5,700
Change (1Y)
-300
Growth (1Y)
-5.00%
Revenue / Employee
$1,017,018
Profits / Employee
-$53,333
Market Cap
2.29B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5,700 | -300 | -5.00% |
| Dec 31, 2024 | 6,000 | -200 | -3.23% |
| Dec 31, 2023 | 6,200 | -400 | -6.06% |
| Dec 31, 2022 | 6,600 | 200 | 3.13% |
| Dec 31, 2021 | 6,400 | -100 | -1.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| H.B. Fuller Company | 7,100 |
| Quaker Chemical | 4,700 |
| Minerals Technologies | 3,782 |
| Ashland | 2,900 |
| Innospec | 2,450 |
| Stepan Company | 2,328 |
| Calumet | 1,540 |
| Ingevity | 1,500 |
CC News
- 3 days ago - Chemours price target lowered to $18 from $21 at Morgan Stanley - TheFly
- 3 days ago - Chemours price target lowered to $18 from $21 at Morgan Stanley - TheFly
- 3 days ago - Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments - PRNewsWire
- 3 days ago - Chemours downgraded to Neutral from Buy at UBS - TheFly
- 5 days ago - New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval - Reuters
- 7 days ago - Chemours price target lowered to $24 from $30 at Truist - TheFly
- 7 days ago - Chemours price target lowered to $22 from $26 at RBC Capital - TheFly
- 8 days ago - The Chemours Company Earnings Call Transcript: Q2 2026 - Transcripts